Funded Startups in Seocho
Seocho’s five most recent funded entries (all in Seocho, South Korea) cluster tightly in early November 2025: four rounds fall between 2025-11-04 and 2025-…
Seocho’s five most recent funded entries (all in Seocho, South Korea) cluster tightly in early November 2025: four rounds fall between 2025-11-04 and 2025-11-18, with the latest dated close on 2025-11-22 (Redrob, Series A, $9M). Disclosed round sizes show a clear outlier pattern: Redrob’s $9M is the largest disclosed amount, while the remaining disclosed figures are $7M (Korea Deep Learning on 2025-10-01) and $3M (Return Zero on 2025-11-05), with two additional companies listing “undisclosed” amounts (CloudHospital on 2025-11-18; S-Alpha Therapeutics on 2025-11-04). Sector coverage is led by AI: three of the five entries list AI in the sector field (Redrob; Return Zero; Korea Deep Learning). Stage mix is also concentrated, with Series A appearing twice (Redrob 2025-11-22, $9M; Korea Deep Learning 2025-10-01, $7M) and Series C appearing twice (Return Zero 2025-11-05, $3M; S-Alpha Therapeutics 2025-11-04, undisclosed).
Most recent rounds
5 shownRelated listings
Frequently asked
Which is the largest disclosed round in Seocho here, and how does it compare with the other disclosed amounts?
Redrob’s $9M Series A (2025-11-22) is the largest disclosed amount in the five-row list. The next-highest disclosed amounts are $7M (Korea Deep Learning, Series A, 2025-10-01) and $3M (Return Zero, Series C, 2025-11-05), with CloudHospital (2025-11-18) and S-Alpha Therapeutics (2025-11-04) both marked “undisclosed.”
How concentrated are these deals in time within Seocho?
Four of the five rounds are dated between 2025-11-04 and 2025-11-18 (S-Alpha Therapeutics on 2025-11-04, Return Zero on 2025-11-05, CloudHospital on 2025-11-18, and Redrob on 2025-11-22 aside from the late-October entry). The span covered by the shown rows runs from 2025-10-01 (Korea Deep Learning) through 2025-11-22 (Redrob).
Are any sectors over-represented among these Seocho entries?
AI appears in 3 of the 5 entries: Redrob (AI; Series A; 2025-11-22; $9M), Return Zero (AI; Series C; 2025-11-05; $3M), and Korea Deep Learning (AI; Series A; 2025-10-01; $7M). Healthcare shows up in 2 of the 5 entries (CloudHospital and S-Alpha Therapeutics), both of which have “undisclosed” amounts in this view.
What does the stage mix look like, especially around disclosed vs undisclosed amounts?
Series A and Series C each appear twice: Series A includes Redrob ($9M, 2025-11-22) and Korea Deep Learning ($7M, 2025-10-01), while Series C includes Return Zero ($3M, 2025-11-05) and S-Alpha Therapeutics (undisclosed, 2025-11-04). The undisclosed amounts belong to CloudHospital (Series A, 2025-11-18) and S-Alpha Therapeutics (Series C, 2025-11-04).
Are there outliers in either sector or round disclosure worth drilling into?
For disclosure, the outlier is the split between three clearly disclosed amounts ($9M on 2025-11-22 by Redrob; $7M on 2025-10-01 by Korea Deep Learning; $3M on 2025-11-05 by Return Zero) and two “undisclosed” rounds (CloudHospital, 2025-11-18; S-Alpha Therapeutics, 2025-11-04). For sector, AI is concentrated across three companies, whereas the two healthcare entries are the only ones without disclosed amounts in this slice.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.